HK1109391A1 - Adduct of fluorescent dye and tumor avid tetrapyrrole - Google Patents
Adduct of fluorescent dye and tumor avid tetrapyrroleInfo
- Publication number
- HK1109391A1 HK1109391A1 HK07113967.5A HK07113967A HK1109391A1 HK 1109391 A1 HK1109391 A1 HK 1109391A1 HK 07113967 A HK07113967 A HK 07113967A HK 1109391 A1 HK1109391 A1 HK 1109391A1
- Authority
- HK
- Hong Kong
- Prior art keywords
- compound
- fluorescent dye
- tumor
- preferential
- adduct
- Prior art date
Links
- 206010028980 Neoplasm Diseases 0.000 title abstract 5
- 239000007850 fluorescent dye Substances 0.000 title abstract 3
- 150000001875 compounds Chemical class 0.000 abstract 5
- 238000010521 absorption reaction Methods 0.000 abstract 3
- 150000004036 bacteriochlorins Chemical class 0.000 abstract 1
- 150000004035 chlorins Chemical class 0.000 abstract 1
- 239000000975 dye Substances 0.000 abstract 1
- MOFVSTNWEDAEEK-UHFFFAOYSA-M indocyanine green Chemical compound [Na+].[O-]S(=O)(=O)CCCCN1C2=CC=C3C=CC=CC3=C2C(C)(C)C1=CC=CC=CC=CC1=[N+](CCCCS([O-])(=O)=O)C2=CC=C(C=CC=C3)C3=C2C1(C)C MOFVSTNWEDAEEK-UHFFFAOYSA-M 0.000 abstract 1
- 229960004657 indocyanine green Drugs 0.000 abstract 1
- 230000004807 localization Effects 0.000 abstract 1
- 150000004033 porphyrin derivatives Chemical class 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B10/00—Other methods or instruments for diagnosis, e.g. instruments for taking a cell sample, for biopsy, for vaccination diagnosis; Sex determination; Ovulation-period determination; Throat striking implements
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K49/00—Preparations for testing in vivo
- A61K49/001—Preparation for luminescence or biological staining
- A61K49/0013—Luminescence
- A61K49/0017—Fluorescence in vivo
- A61K49/0019—Fluorescence in vivo characterised by the fluorescent group, e.g. oligomeric, polymeric or dendritic molecules
- A61K49/0021—Fluorescence in vivo characterised by the fluorescent group, e.g. oligomeric, polymeric or dendritic molecules the fluorescent group being a small organic molecule
- A61K49/0032—Methine dyes, e.g. cyanine dyes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/05—Detecting, measuring or recording for diagnosis by means of electric currents or magnetic fields; Measuring using microwaves or radio waves
- A61B5/055—Detecting, measuring or recording for diagnosis by means of electric currents or magnetic fields; Measuring using microwaves or radio waves involving electronic [EMR] or nuclear [NMR] magnetic resonance, e.g. magnetic resonance imaging
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
- A61K41/0057—Photodynamic therapy with a photosensitizer, i.e. agent able to produce reactive oxygen species upon exposure to light or radiation, e.g. UV or visible light; photocleavage of nucleic acids with an agent
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
- A61K41/0057—Photodynamic therapy with a photosensitizer, i.e. agent able to produce reactive oxygen species upon exposure to light or radiation, e.g. UV or visible light; photocleavage of nucleic acids with an agent
- A61K41/0071—PDT with porphyrins having exactly 20 ring atoms, i.e. based on the non-expanded tetrapyrrolic ring system, e.g. bacteriochlorin, chlorin-e6, or phthalocyanines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K49/00—Preparations for testing in vivo
- A61K49/001—Preparation for luminescence or biological staining
- A61K49/0013—Luminescence
- A61K49/0017—Fluorescence in vivo
- A61K49/005—Fluorescence in vivo characterised by the carrier molecule carrying the fluorescent agent
- A61K49/0052—Small organic molecules
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B47/00—Formation or introduction of functional groups not provided for in groups C07B39/00 - C07B45/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/22—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains four or more hetero rings
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Epidemiology (AREA)
- Biomedical Technology (AREA)
- Molecular Biology (AREA)
- Engineering & Computer Science (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Biochemistry (AREA)
- Surgery (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pathology (AREA)
- Heart & Thoracic Surgery (AREA)
- Medical Informatics (AREA)
- Physics & Mathematics (AREA)
- High Energy & Nuclear Physics (AREA)
- Radiology & Medical Imaging (AREA)
- Biophysics (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US58887604P | 2004-07-16 | 2004-07-16 | |
| PCT/US2005/024782 WO2006019775A1 (en) | 2004-07-16 | 2005-07-13 | Adduct of fluorescent dye and tumor avid tetrapyrrole |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| HK1109391A1 true HK1109391A1 (en) | 2008-06-06 |
Family
ID=35907707
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| HK07113967.5A HK1109391A1 (en) | 2004-07-16 | 2007-12-20 | Adduct of fluorescent dye and tumor avid tetrapyrrole |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US7947729B2 (zh) |
| EP (1) | EP1781170B1 (zh) |
| JP (1) | JP4733126B2 (zh) |
| KR (1) | KR101194486B1 (zh) |
| CN (1) | CN1984915B (zh) |
| AU (1) | AU2005275220B2 (zh) |
| HK (1) | HK1109391A1 (zh) |
| WO (1) | WO2006019775A1 (zh) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8906354B2 (en) | 2007-02-28 | 2014-12-09 | Bruker Biospin Corporation | Loaded latex optical molecular imaging probes containing lipophilic large stokes shift dyes |
| US8017104B2 (en) | 2007-02-28 | 2011-09-13 | Carestream Health, Inc. | Large stoke shift dye used for optical imaging |
| US10568963B2 (en) * | 2009-10-21 | 2020-02-25 | Health Research, Inc. | Multifunctional nanoplatforms for fluorescence imaging and photodynamic therapy developed by post-loading photosensitizer and fluorophore to polyacrylamide nanoparticles |
| US8609837B2 (en) * | 2010-07-06 | 2013-12-17 | Health Research, Inc. | Metallation enhancements in tumor-imaging and PDT therapy |
| WO2014022742A1 (en) * | 2012-08-03 | 2014-02-06 | Health Research, Inc. | Paa nanoplatforms containing fluorophores and targeted moieties covalently linked and photosensitizer post-loaded |
| CN103911017B (zh) | 2012-12-28 | 2017-09-15 | 浙江海正药业股份有限公司 | 菁染料化合物及其制备方法、用于光动力学疗法的双重功能剂及其制备方法 |
| TWI650137B (zh) * | 2017-09-01 | 2019-02-11 | 行政院原子能委員會核能硏究所 | 多功能探針及其用途 |
| US20200289676A1 (en) * | 2019-03-15 | 2020-09-17 | Lahjavida, Llc | Near-Infrared Dyes And Conjugates For Targeting Tumors |
Family Cites Families (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4649151A (en) | 1982-09-27 | 1987-03-10 | Health Research, Inc. | Drugs comprising porphyrins |
| US4968715A (en) | 1988-07-06 | 1990-11-06 | Health Research, Inc. | Use of purified hematoporphyrin trimers in photodynamic therapy |
| US5002962A (en) | 1988-07-20 | 1991-03-26 | Health Research, Inc. | Photosensitizing agents |
| US5198460A (en) | 1988-07-20 | 1993-03-30 | Health Research Inc. | Pyropheophorbides and their use in photodynamic therapy |
| US5707986A (en) * | 1994-03-14 | 1998-01-13 | Miller; Joan W. | Angiographic method using green porphyrins in primate eyes |
| US5498710A (en) | 1994-04-22 | 1996-03-12 | Health Research, Inc. | Alkyl ether analogues of benzoporphyrin derivatives |
| US5591847A (en) | 1994-05-23 | 1997-01-07 | Health Research, Inc. | Long wavelength absorbing photosensitizers related to purpurin-18, bacteriopurpurin-18 and related compounds with imide linkages |
| US6103751A (en) | 1998-06-22 | 2000-08-15 | Health Research, Inc. | Carotene analogs of porphyrins, chlorins and bacteriochlorins as therapeutic and diagnostic agents |
| US20030105300A1 (en) * | 2001-10-17 | 2003-06-05 | Mallinckrodt Inc. | Tumor targeted photodiagnostic-phototherapeutic agents |
| US20030105299A1 (en) * | 2001-10-17 | 2003-06-05 | Mallinckrodt Inc. | Carbocyanine dyes for tandem, photodiagnostic and therapeutic applications |
| US6761878B2 (en) * | 2001-10-17 | 2004-07-13 | Mallinckrodt, Inc. | Pathological tissue detection and treatment employing targeted benzoindole optical agents |
| US20030152577A1 (en) * | 2002-02-07 | 2003-08-14 | Mallinckrodt Inc. | Dye-bioconjugates for simultaneous optical diagnostic and therapeutic applications |
-
2005
- 2005-07-13 US US11/632,433 patent/US7947729B2/en not_active Expired - Fee Related
- 2005-07-13 CN CN2005800240061A patent/CN1984915B/zh not_active Expired - Fee Related
- 2005-07-13 JP JP2007521591A patent/JP4733126B2/ja not_active Expired - Fee Related
- 2005-07-13 KR KR1020077002082A patent/KR101194486B1/ko active IP Right Grant
- 2005-07-13 WO PCT/US2005/024782 patent/WO2006019775A1/en active Application Filing
- 2005-07-13 AU AU2005275220A patent/AU2005275220B2/en not_active Ceased
- 2005-07-13 EP EP05773299.2A patent/EP1781170B1/en not_active Not-in-force
-
2007
- 2007-12-20 HK HK07113967.5A patent/HK1109391A1/xx not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| EP1781170B1 (en) | 2014-04-30 |
| KR20070036152A (ko) | 2007-04-02 |
| CN1984915B (zh) | 2012-12-19 |
| US20090043090A1 (en) | 2009-02-12 |
| WO2006019775A1 (en) | 2006-02-23 |
| JP4733126B2 (ja) | 2011-07-27 |
| EP1781170A1 (en) | 2007-05-09 |
| JP2008506694A (ja) | 2008-03-06 |
| CN1984915A (zh) | 2007-06-20 |
| EP1781170A4 (en) | 2011-01-05 |
| US7947729B2 (en) | 2011-05-24 |
| AU2005275220B2 (en) | 2012-02-02 |
| KR101194486B1 (ko) | 2012-10-24 |
| AU2005275220A1 (en) | 2006-02-23 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HK1109391A1 (en) | Adduct of fluorescent dye and tumor avid tetrapyrrole | |
| Li et al. | A lysosome-targeted BODIPY as potential NIR photosensitizer for photodynamic therapy | |
| Hamblin | Advances in photodynamic therapy: basic, translational, and clinical | |
| He et al. | Preparation of unsymmetrical distyryl BODIPY derivatives and effects of the styryl substituents on their in vitro photodynamic properties | |
| Yu et al. | Chemical modification of temoporfin–a second generation photosensitizer activated using upconverting nanoparticles for singlet oxygen generation | |
| US11493785B2 (en) | Phototherapeutic near IR fluorescent light filters | |
| CN101102766B (zh) | 新型卟啉衍生物，尤其二氢卟酚和/或菌绿素及其在光动力学治疗中的应用 | |
| Braslavsky et al. | Photophysical properties of porphycene derivatives (18 π porphyrinoids) | |
| WO2001039764A3 (en) | Methods for treating conditions and illnesses associated with abnormal vasculature | |
| Lange et al. | Photosensitizers for photodynamic therapy: Photochemistry in the service of oncology | |
| WO2002096366A3 (en) | Metallotetrapyrrolic photosensitizing agents for use in photodynamic therapy | |
| WO2004035590A3 (en) | Meso-substituted porphyrins | |
| Hao et al. | Synthesis and biological investigations of tetrakis (p-carboranylthio-tetrafluorophenyl) chlorin (TPFC) | |
| Horne et al. | Mechanistics and photo‐energetics of macrocycles and photodynamic therapy: An overview of aspects to consider for research | |
| Nonell et al. | Synthesis, optical absorption and photophysical properties of cone-shaped subnaphthalocyanine | |
| Gülmez et al. | Silicon (IV) phthalocyanine-biotin conjugates: Synthesis, photophysicochemical properties and in vitro biological activity for photodynamic therapy | |
| Huang et al. | Preparation and in vitro photodynamic activity of novel silicon (IV) phthalocyanines conjugated to serum albumins | |
| Kostron et al. | Photodynamic therapy | |
| EP1424942A4 (en) | PORPHYRINS WITH EFFICIENT MULTI-PHOTON ABSORPTION SECTION FOR PHOTODYNAMIC THERAPY | |
| Cañete et al. | Photosensitizing properties of palladium-tetraphenylporphycene on cultured tumour cells | |
| Mitzel et al. | The Synthesis of Arylalkyne‐Substituted Tetrapyrazinoporphyrazines and an Evaluation of Their Potential as Photosensitisers for Photodynamic Therapy | |
| Canete et al. | Meso-tetraphenylporphyrin: photosensitizing properties and cytotoxic effects on cultured tumor cells. | |
| Gorman et al. | An overview of synthetic approaches to porphyrin, phthalocyanine, and phenothiazine photosensitizers for photodynamic therapy | |
| Zhang et al. | Antitumor activity evaluation of meso-tetra (pyrrolidine substituted) pentylporphin-mediated photodynamic therapy in vitro and in vivo | |
| Ogura et al. | Improvement of tumor localization of photosensitizers for photodynamic therapy and its application for tumor diagnosis |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PC | Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee) |
Effective date: 20200707 |